Immediate efficacy of percutaneous transhepatic obliteration and sclerotherapy for giant pipeline esophageal varices hemorrhage in a patient with liver cirrhosis type C

Toru Ishikawa,Akito Iwanaga,Takashi Owaki,Yujiro Nozawa,Michitaka Imai,Keiichi Seki,Tomoe Sano,Toshiaki Yoshida,Terasu Honma,Hiroki Sato

doi:10.15761/gii.1000123

Abstract

Immediate efficacy of percutaneous transhepatic obliteration and sclerotherapy for giant pipeline esophageal varices hemorrhage in a patient with liver cirrhosis type C

Highlights

Percutaneous transhepatic obliteration (PTO) was firstly reported by Lunderquist in 1974 [2]
A 5‐French gauge sheath catheter was introduced into the portal vein
A coaxial catheter was inserted into these feeding veins while avoiding the main feeding vein

Summary

Introduction

PTO was firstly reported by Lunderquist in 1974 [2]. This treatment had been widely performed as an emergency measure in cases of variceal hemorrhage [2]. A 49-year-old man was referred to us with a diagnosis of hematemesis by giant pipeline esophageal varices due to liver cirrhosis hepatitis C infection after carving a tattoo at 20-year age (Figures 1A & 1B). Endoscopic injection sclerotherapy (EIS) was generally treated esophageal varices.

Results

Conclusion